Zheng Y. Zhang
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Significance of Mutation Spots and Concurrent Gene Mutations on Prognosis and Clinical Outcomes in Myelodysplastic Syndromes With SF3B1 Mutation.
Journal: Cancer medicine
Published: August 28, 2024
Eltrombopag restores proliferative capacity and adipose-osteogenic balance of mesenchymal stromal cells in low-risk myelodysplastic syndromes.
Journal: European journal of pharmacology
Published: June 24, 2024
Comparison of the two histological subtypes of ampullary adenocarcinoma: a retrospective study.
Journal: Cirugia y cirujanos
Published: May 23, 2024
Prognostic significance of LRPPRC and its association with immune infiltration in liver hepatocellular carcinoma.
Journal: American journal of clinical and experimental immunology
Published: February 20, 2024
ROBO1 deficiency impairs HSPC homeostasis and erythropoiesis via CDC42 and predicts poor prognosis in MDS.
Journal: Science advances
Published: November 29, 2023
Somatic mutations in SF3B1 aberrant-negative MDS-RS most commonly involved in TP53 genes.
Journal: Journal of cellular and molecular medicine
Published: January 27, 2022
NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy.
Journal: British journal of haematology
Published: January 31, 2020
IGF‑IR promotes clonal cell proliferation in myelodysplastic syndromes via inhibition of the MAPK pathway.
Journal: Oncology reports
Published: September 11, 2019
The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine.
Journal: Journal of cancer research and clinical oncology
Published: April 20, 2019
Expression of Insulin-like Growth Factor Recepter Type I in CD34+ Cells of Patients with Myelodysplastic Syndromes
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 29, 2018
Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes.
Journal: Scientific reports
Published: September 05, 2016
Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.
Journal: Scientific reports
Published: January 11, 2016
Last Updated: 09/26/2026